In Vitro & In Vivo Diagnostic Substances · CIK 1906324
QuidelOrtho Corp advances diagnostics for a healthier future through immunoassay, molecular, clinical chemistry, and transfusion medicine testing
Comparable business profile · signals at a glance
In the 90 days to Feb 13, 2026: 6 insiders bought $1.3M · 1 sold $112K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 13, 2026 | Blaser Brian J.President and CEO | Buy | 10,540 | $23.59 | $249K |
| Feb 13, 2026 | Strobeck MatthewDirector | Buy | 10,000 | $23.96 | $240K |
| Feb 13, 2026 | Busky Joseph M.Chief Financial Officer | Buy | 3,370 | $23.66 | $80K |
| Feb 13, 2026 | Busky Joseph M.Chief Financial Officer | Buy | 3,370 | $23.66 | $80K |
| Dec 10, 2025 | Rhoads Ann DDirector | Buy | 750 | $28.28 | $21K |
| Nov 26, 2025 | Wilkins Joseph D Jr.Director | Buy | 370 | $27.96 | $10K |
| Nov 25, 2025 | Widder Kenneth JDirector | Sell | 4,026 | $27.81 | $112K |
| Nov 24, 2025 | Busky Joseph M.Chief Financial Officer | Buy | 4,770 | $26.06 | $124K |
| Nov 21, 2025 | Polan Mary Lake Ph DDirector | Buy | 1,000 | $22.43 | $22K |
| Nov 19, 2025 | Blaser Brian J.President and CEO | Buy | 23,500 | $21.34 | $501K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.